Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) has announced its upcoming second quarter 2024 financial results conference call and webcast, scheduled for August 8, 2024, at 8:30 a.m. ET. The event will cover financial results for the quarter ended June 30, 2024. Participants can access the call via phone by registering online to receive a dial-in number and personal PIN. A live audio webcast and presentation materials will be available through the Investors section of the Amicus Therapeutics website.

Amicus Therapeutics is a global biotechnology company focused on discovering, developing, and delivering novel medicines for rare diseases. The company emphasizes patient dedication and is committed to advancing a pipeline of first- or best-in-class treatments for rare diseases.

Positive

• Timely financial reporting with scheduled Q2 2024 results announcement
• Continued focus on rare disease treatments, potentially addressing unmet medical needs
• Multiple access options for investors (phone and webcast) for the earnings call

Negative

• None.

PRINCETON, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 8, 2024, at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2024.

Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.

An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

FOLD–G

FAQ

When will Amicus Therapeutics (FOLD) release its Q2 2024 financial results?

Amicus Therapeutics (FOLD) will release its Q2 2024 financial results on August 8, 2024, during a conference call and webcast at 8:30 a.m. ET.

How can investors access Amicus Therapeutics' (FOLD) Q2 2024 earnings call?

Investors can access the Q2 2024 earnings call by registering online for a phone dial-in and PIN, or by joining the live audio webcast through the Investors section of the Amicus Therapeutics website.

What is the main focus of Amicus Therapeutics (FOLD)?

Amicus Therapeutics (FOLD) is a global biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases.

What period will Amicus Therapeutics' (FOLD) Q2 2024 financial results cover?

Amicus Therapeutics' (FOLD) Q2 2024 financial results will cover the quarter ended June 30, 2024.